Linked-read whole-genome sequencing resolves common and private structural variants in multiple myeloma.
Lucía Peña-PérezNicolai Sebastian FrengenJulia HauensteinCharlotte GranCharlotte GustafssonJesper EisfeldtMarcin KierczakFanny Taborsak-LinesRemi-André OlsenAnn WallblomAleksandra KrsticPhilip EwelsAnna LindstrandRobert MånssonPublished in: Blood advances (2022)
Multiple myeloma (MM) is an incurable and aggressive plasma cell malignancy characterized by a complex karyotype with multiple structural variants (SVs) and copy-number variations (CNVs). Linked-read whole-genome sequencing (lrWGS) allows for refined detection and reconstruction of SVs by providing long-range genetic information from standard short-read sequencing. This makes lrWGS an attractive solution for capturing the full genomic complexity of MM. Here we show that high-quality lrWGS data can be generated from low numbers of cells subjected to fluorescence-activated cell sorting (FACS) without DNA purification. Using this protocol, we analyzed MM cells after FACS from 37 patients with MM using lrWGS. We found high concordance between lrWGS and fluorescence in situ hybridization (FISH) for the detection of recurrent translocations and CNVs. Outside of the regions investigated by FISH, we identified >150 additional SVs and CNVs across the cohort. Analysis of the lrWGS data allowed for resolution of the structure of diverse SVs affecting the MYC and t(11;14) loci, causing the duplication of genes and gene regulatory elements. In addition, we identified private SVs causing the dysregulation of genes recurrently involved in translocations with the IGH locus and show that these can alter the molecular classification of MM. Overall, we conclude that lrWGS allows for the detection of aberrations critical for MM prognostics and provides a feasible route for providing comprehensive genetics. Implementing lrWGS could provide more accurate clinical prognostics, facilitate genomic medicine initiatives, and greatly improve the stratification of patients included in clinical trials.
Keyphrases
- copy number
- genome wide
- single molecule
- mitochondrial dna
- multiple myeloma
- dna methylation
- single cell
- induced apoptosis
- clinical trial
- cell cycle arrest
- atomic force microscopy
- loop mediated isothermal amplification
- healthcare
- newly diagnosed
- electronic health record
- cell death
- quality improvement
- real time pcr
- health insurance
- randomized controlled trial
- cell therapy
- stem cells
- oxidative stress
- ejection fraction
- deep learning
- endoplasmic reticulum stress
- social media
- signaling pathway
- gene expression
- genome wide association study
- circulating tumor
- prognostic factors
- bone marrow
- cell free
- study protocol
- pi k akt
- mass spectrometry
- phase iii
- artificial intelligence